Scarica l'app Stockscreener
4.44
5.53%
-0.26
Dopo l'orario di chiusura:
4.49
0.05
+1.13%
Curevac N V Borsa (CVAC) Ultime notizie
CureVac (NASDAQ:CVAC) Shares Purchased by Northern Trust Corp - Defense World
CureVac: Successful cash burn reduction - marketscreener.com
CureVac (NASDAQ:CVAC) Given “Market Outperform” Rating at JMP Securities - Defense World
D. E. Shaw & Co. Inc. Purchases New Position in CureVac (NASDAQ:CVAC) - Defense World
CureVac (CVAC) Maintains Market Outperform Rating with Stable Price Target | CVAC Stock News - GuruFocus
CureVac stock maintains $10 target from JMP on GBM vaccine outlook - Investing.com UK
Millennium Management LLC Sells 771,136 Shares of CureVac (NASDAQ:CVAC) - Defense World
The Strong Earnings Posted By CureVac (NASDAQ:CVAC) Are A Good Indication Of The Strength Of The Business - simplywall.st
We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative - Yahoo
CureVac First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
CureVac FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World
BNP Paribas Financial Markets Takes $585,000 Position in CureVac (NASDAQ:CVAC) - Defense World
CureVac Announces Annual General Meeting for June 2025 - TipRanks
Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
CureVac NV reports results for the quarter ended March 31Earnings Summary - TradingView
CureVac price target lowered to $2 from $2.50 at BofA - TipRanks
CureVac (CVAC): BofA Reduces Price Target Amidst Ongoing Challen - GuruFocus
CureVac N.V. Reports Q1 2025 Financial Results Amid Strategic Restructuring - TipRanks
CureVac Reports Q1 2025 Financial Results Amid Revenue Decline - TipRanks
CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction - Benzinga
CVAC Reduces Operating Loss in Q1 2025 Amid Strong Pipeline Progress | CVAC Stock News - GuruFocus
CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates - ACCESS Newswire
CureVac Secures Major FDA Win for Cancer Drug While Patent Battle Against BioNTech Heats Up - Stock Titan
Curevac Q1 Revenue Eur 900 Thousand - marketscreener.com
CureVac granted favorable decision by European Patent Office vs. BioNTech - TipRanks
CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE | CVAC Stock News - GuruFocus
CureVac Secures Critical Second Patent Win vs BioNTechJuly Court Showdown Set for mRNA Rights - Stock Titan
CureVac Secures Key Patent Victory in Litigation with BioNTech - TipRanks
Barclays PLC Has $118,000 Stake in CureVac (NASDAQ:CVAC) - Defense World
CureVac (CVAC) to Release Earnings on Thursday - Defense World
Analysts Offer Valuable Insight On CureVac N.V (CVAC) - Stocksregister
CureVac (NASDAQ:CVAC) Shares Gap Up – Should You Buy? - Defense World
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK - ACCESS Newswire
Geode Capital Management LLC Acquires 22,491 Shares of CureVac (NASDAQ:CVAC) - Defense World
UBS Group Lowers CureVac (NASDAQ:CVAC) Price Target to $12.00 - Defense World
CVAC (CureVac N.V) has impressive results - uspostnews.com
CureVac N.V. (NASDAQ:CVAC) Shares Fly 31% But Investors Aren't Buying For Growth - simplywall.st
Legal & General Group Plc Has $359,000 Holdings in CureVac (NASDAQ:CVAC) - Defense World
Understanding the Risks of Investing in CureVac N.V (CVAC) - knoxdaily.com
CureVac (CVAC) Target Price Reduced by UBS Analyst | CVAC Stock News - GuruFocus
UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating - marketscreener.com
CureVac's CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet - ACCESS Newswire
CureVac N.V (CVAC) Stock: Navigating a Year of Stock Volatility - investchronicle.com
CureVac (NASDAQ:CVAC) Shares Gap Up – Here’s Why - Defense World
Can you still get a good price for CureVac N.V (CVAC) Shares at this point? - uspostnews.com
CureVac (CVAC) to Release Quarterly Earnings on Wednesday - Defense World
CureVac Among 3 Promising Penny Stocks To Watch - Yahoo Finance
CureVac (NASDAQ:CVAC) Trading Up 7.5% – Should You Buy? - Defense World
CureVac N.V. (NASDAQ:CVAC) Q4 2024 Earnings Call Transcript - Insider Monkey
CureVac N.V. Earnings Call: Financial Strength Amid Challenges - TipRanks
CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode - MSN
CureVac NV earnings beat by €0.06, revenue topped estimates - Investing.com South Africa
CureVac N.V. Reports Earnings Results for the Full Year Ended December 31, 2024 - marketscreener.com
CureVac: 2025 will be less costly - marketscreener.com
CureVac Announces Financial Results for the Fourth Quarter and F - GuruFocus
CureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial Resilience - Yahoo Finance
CureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial Resilience By GuruFocus - Investing.com Canada
0.00%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):